_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc-preview-1.jpg "REFINE: a real-world analysis of regorafenib in patients with unresectable HCC from regorafenib nivolumab asco Video Screenshot Preview 1")
Gallery_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc-preview-3.jpg "REFINE: a real-world analysis of regorafenib in patients with unresectable HCC from regorafenib nivolumab asco Video Screenshot Preview 3")
Gallery_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc-preview-hqdefault.jpg "REFINE: a real-world analysis of regorafenib in patients with unresectable HCC from regorafenib nivolumab asco Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 52 seconds
👁 View: 46 times
Play Audio:👁 View: 46 times
Description:
VJOncology
VJOncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_combination-therapy-updates-from-asco-2019.webp "OncLiveTV")
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.webp "VJOncology")
_therapeutic-approach-for-hcc-progression.webp "Targeted Oncology")
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.webp "VJOncology")
⏲ 2 minutes 52 seconds 👁 46
_regorafenib-in-colorectal-cancer.webp "OncLiveTV")
_dr-lopes-on-the-fda-approval-of-nivolumab-ipilimumab-in-nsclc.webp "OncLiveTV")
_real-world-use-of-nivolumab-in-gastric-cancer.webp "VJOncology")
_alan-venook-md-relays-the-optimal-dose-for-regorafenib-stivarga-in-the-2nd-line-treatment-of-mcrc.webp "OBRoncology")
Alan Venook, MD relays the optimal dose for regorafenib (Stivarga) in the 2nd line treatment of mCRC
⏲ 1 minute 47 seconds 👁 61
_combination-therapy-updates-from-asco-2019.jpg)
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.jpg)
_therapeutic-approach-for-hcc-progression.jpg)
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.jpg)
_regorafenib-in-colorectal-cancer.jpg)
_dr-lopes-on-the-fda-approval-of-nivolumab-ipilimumab-in-nsclc.jpg)
_real-world-use-of-nivolumab-in-gastric-cancer.jpg)
_alan-venook-md-relays-the-optimal-dose-for-regorafenib-stivarga-in-the-2nd-line-treatment-of-mcrc.jpg)
![[+]](/images/menu.gif){kind=small}